Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model

Beneficial Microbes

Volumn 7, Issue 1, 2016, Pages 75-82

  Satoh, T ^a   Izumi, H ^a   Iwabuchi, N ^a   Odamaki, T ^a   Namba, K ^a   Abe, F ^a   Xiao, J Z ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Bifidobacterium; Necrotising enterocolitis; Toll like receptors

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CHEMOKINE; CYTOKINE; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL MILK; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; ILEUM; LIMIT OF DETECTION; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SURVIVAL RATE; SURVIVAL TIME; ANIMAL; DISEASE MODEL; ENTEROCOLITIS, NECROTIZING; INFLAMMATION; METABOLISM; SPRAGUE DAWLEY RAT; SURVIVAL ANALYSIS;

ANIMALS; BIFIDOBACTERIUM BREVE; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; GENE EXPRESSION; ILEUM; INFLAMMATION; INFLAMMATION MEDIATORS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTORS;

EID: 84958206021     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0035     Document Type: Article

References (34)

1. Afrazi, A., Sodhi, C.P., Richardson, W., Neal, M., Good, M., Siggers, R. and Hackam, D.J., 2011. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatric Research 69: 183-188.
2. Benkoe, T., Baumann, S., Weninger, M., Pones, M., Reck, C., Rebhandl, W. and Oehler, R., 2013. Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PloS One 8: e58720.
3. Bergmann, K.R., Liu, S.X.L., Tian, R., Kushnir, A., Turner, J.R., Li, H.-L. and De Plaen, I.G., 2013. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. American Journal of Pathology 182: 1595-1606.
4. Cario, E., Gerken, G. and Podolsky, D.K., 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.
5. Chavez, A.M., Menconi, M.J., Hodin, R.A. and Fink, M.P., 1999. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Critical Care Medicine 27: 2246-2251.
6. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W. and Boirivant, M., 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. Journal of Immunology 174: 3237-3246.
7. Fujie, H., Villena, J., Tohno, M., Morie, K., Shimazu, T., Aso, H. and Kitazawa, H., 2011. Toll-like receptor-2-activating bifidobacteria strains differentially regulate inflammatory cytokines in the porcine intestinal epithelial cell culture system: finding new anti-inflammatory immunobiotics. FEMS Immunology and Medical Microbiology 63: 129-139.
8. Fujii, T., Ohtsuka, Y., Lee, T., Kudo, T., Shoji, H., Sato, H. and Yamashiro, Y., 2006. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. Journal of Pediatric Gastroenterology and Nutrition 43: 83-88.
9. Gassler, N., Rohr, C., Schneider, A., Kartenbeck, J., Bach, A., Obermüller, N. and Autschbach, F., 2001. Inflammatory bowel disease is associated with changes of enterocytic junctions. American Journal of Physiology - Gastrointestinal and Liver Physiology 281: G216-G228.
10. Grave, G.D., Nelson, S.A., Walker, W.A., Moss, R.L., Dvorak, B., Hamilton, F.A. and Raju, T.N.K., 2007. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatric Research 62: 510-514.
11. Hackam, D.J., Afrazi, A., Good, M. and Sodhi, C.P., 2013. Innate immune signaling in the pathogenesis of necrotizing enterocolitis. Clinical and Developmental Immunology 2013: 475415.
12. Holman, R.C., Stoll, B.J., Curns, A.T., Yorita, K.L., Steiner, C.A. and Schonberger, L.B., 2006. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatric and Perinatal Epidemiology 20: 498-506.
13. Hoyos, A., 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. International Journal of Infectious Diseases 3: 197-202.
14. Hunter, C., Dimaguila, M.A.V.T., Gal, P., Wimmer, J.E., Ransom, J.L., Carlos, R.Q. and Davanzo, C.C., 2012. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis. BMC Pediatrics 12: 142.
15. Hunter, C.J., Williams, M., Petrosyan, M., Guner, Y., Mittal, R., Mock, D. and Prasadarao, N.V., 2009. Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infection and Immunity 77: 1031-1043.
16. Jantscher-Krenn, E., Zherebtsov, M., Nissan, C., Goth, K., Guner, Y.S., Naidu, N. and Bode, L., 2012. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 61: 1417-1425.
17. Jilling, T., Simon, D., Lu, J., Meng, F.J., Li, D., Schy, R. and Caplan, M.S., 2006. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. Journal of Immunology 177: 3273-3282.
18. Khailova, L., Dvorak, K., Arganbright, K. M., Halpern, M. D., Kinouchi, T., Yajima, M. and Dvorak, B., 2009. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 297: G940-G949.
19. Khailova, L., Mount Patrick, S.K., Arganbright, K.M., Halpern, M.D., Kinouchi, T. and Dvorak, B., 2010. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 299: G1118-G1127.
20. Krishnan, J., Selvarajoo, K., Tsuchiya, M., Lee, G. and Choi, S., 2007. Toll-like receptor signal transduction. Experimental and Molecular Medicine, 39: 421-438.
21. Kucharzik, T., Walsh, S.V, Chen, J., Parkos, C.A. and Nusrat, A., 2001. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. American Journal of Pathology 159: 2001-2009.
22. Kwon, H.-K., Lee, C.-G., So, J.-S., Chae, C.-S., Hwang, J.-S., Sahoo, A. and Im, S.-H., 2010. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the USA 107: 2159-2164.
23. Leaphart, C.L., Cavallo, J., Gribar, S.C., Cetin, S., Li, J., Branca, M.F. and Hackam, D.J., 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. Journal of Immunology 179: 4808-4820.
24. Lin, H., Hsu, C., Chen, H. and Chung, M., 2008. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700.
25. Liu, Y., Fatheree, N. Y., Mangalat, N. and Rhoads, J. M., 2012. Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. American Journal of Physiology - Gastrointestinal and Liver Physiology 302: G608-G617.
26. Rojas, M.A., Lozano, J.M., Rojas, M.X., Rodriguez, V.A., Rondon, M.A., Bastidas, J.A. and Arevalo, M., 2012. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130: e1113-e1120.
27. Satoh, Y., Shinohara, K., Umezaki, H., Shoji, H., Satoh, H., Ohtsuka, Y. and Yamashiro, Y., 2007. Bifidobacteria prevents necrotizing enterocolitis and infection in preterm infants. International Journal of Probiotics and Prebiotics 2: 149-154.
28. Sharma, R., Tepas, J.J., Hudak, M.L., Mollitt, D.L., Wludyka, P.S., Teng, R.-J. and Premachandra, B.R., 2007. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. Journal of Pediatric Surgery 42: 454-461.
29. Shimazu, T., Villena, J., Tohno, M., Fujie, H., Hosoya, S., Shimosato, T. and Kitazawa, H., 2012. Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infection and Immunity 80: 276-288.
30. Sodhi, C.P., Neal, M.D., Siggers, R., Sho, S., Ma, C., Branca, M.F. and Hackam, D.J., 2012. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143: 708-718.
31. Tomosada, Y., Villena, J., Murata, K., Chiba, E., Shimazu, T., Aso, H. and Kitazawa, H., 2013. Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One 8: e59259.
32. Tourneur, E. and Chassin, C., 2013. Neonatal immune adaptation of the gut and its role during infections. Clinical and Developmental Immunology 2013: 270301.
33. Von Dossow, V., Rotard, K., Redlich, U., Hein, O.V. and Spies, C.D., 2005. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Critical Care 9: R662-R669.
34. Wu, S.-F., Chiu, H.-Y., Chen, A.-C., Lin, H.-Y., Lin, H.-C. and Caplan, M., 2013. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. Journal of Pediatric Gastroenterology and Nutrition 57: 23-28.